XML 30 R18.htm IDEA: XBRL DOCUMENT v3.4.0.3
Shareholders' Equity
3 Months Ended
Apr. 02, 2016
Stockholders' Equity Note [Abstract]  
Shareholders' Equity
SHAREHOLDERS’ EQUITY
Common Stock
The Board of Directors has approved a repurchase program of up to 3.0 million common shares of Company stock. Management is authorized to effect purchases from time to time in the open market or through privately negotiated transactions. There were no purchases under this program during the three months ended ending April 2, 2016. There are approximately 2.3 million shares of our common stock available for repurchase under this program.

Share-Based Compensation

The majority of the Company’s annual share-based incentive awards are made in the fiscal second quarter.

The Company recognized approximately $3.3 million and $3.0 million in share-based compensation expense for the three months ended April 2, 2016 and April 4, 2015, respectively. The Company recognizes compensation expense on grants of share-based compensation awards on a straight-line basis over the vesting period of each award. The total excess income tax benefit recognized relating to share-based compensation was immaterial for the three months ended April 2, 2016 and was approximately $0.7 million for the three months ended April 4, 2015. As of April 2, 2016, total unrecognized compensation cost related to share-based compensation awards was approximately $21.3 million, net of estimated forfeitures, which the Company expects to recognize over a weighted average period of approximately 1.9 years.

Approximately 2.0 million shares were available for future grant under the 2013 Equity Incentive Plan at April 2, 2016.

Options and Stock Appreciation Rights
The Company uses several forms of share-based incentive awards, including non-qualified stock options, incentive stock options, and stock settled stock appreciation rights (“SARs”). Options and SARs generally vest over 5 years and expire 10 years from the grant date. All grants are made at prices equal to the fair market value of the stock on the grant date. For the three months ended April 2, 2016 and April 4, 2015, expired and canceled shares were immaterial.
The table below presents share-based compensation activity for the three months ended April 2, 2016 and April 4, 2015 (in millions):
 
 
April 2,
2016
 
April 4,
2015
Total intrinsic value of share-based incentive awards exercised
 
$
0.1

 
$
2.8

Cash received from stock option exercises
 
0.5

 
3.0

Income tax benefit from the exercise of stock options
 
0.1

 
1.1



Following is a summary of share-based incentive plan grant activity (options and SARs) for the three months ended April 2, 2016.
Number of Shares Under Options and SARs
Shares
 
Weighted Average Exercise Price
 
Weighted Average Remaining Contractual Term (years)
 
Aggregate Intrinsic Value (in millions)
Exercisable at January 2, 2016
1,548,266

 
$
63.09

 
 
 
 
Granted

 

 
 
 
 
Exercised
(14,506
)
 
46.67

 
 
 
 
Forfeited
(1,933
)
 
75.75

 
 
 
 
Expired
(700
)
 
71.51

 
 
 
 
Outstanding at April 2, 2016
1,531,127

 
$
63.23

 
5.5
 
$
7.7

Exercisable at April 2, 2016
938,291

 
$
57.38

 
4.1
 
$
7.6



Compensation expense recognized related to Options and SARs was $1.2 million for the three months ended April 2, 2016.
As of April 2, 2016, there was $9.8 million of unrecognized compensation cost related to non-vested options and SARs that is expected to be recognized as a change to earnings over a weighted average period of 3.0 years.

The amount of options expected to vest is materially consistent with those outstanding and not yet exercisable.
Restricted Stock Awards and Restricted Stock Units
Restricted stock awards ("RSA") and restricted stock units ("RSU") consist of shares or the rights to shares of the Company's stock. The awards are restricted such that they are subject to substantial risk of forfeiture and to restrictions on their sale or other transfer. As defined in the individual grant agreements, acceleration of vesting may occur under a change in control, or death, disability or normal retirement of the grantee.
Following is a summary of RSA award activity for the three months ended April 2, 2016:
 
 
Shares
 
Weighted Average Fair Value at Grant Date
 
Weighted Average Remaining Contractual Term (years)
Unvested RSAs at January 2, 2016
 
14,400

 
$
78.15

 
0.4
Granted
 

 

 
 
Vested
 

 

 
 
Forfeited
 

 

 
 
Unvested RSAs April 2, 2016
 
14,400

 
$
78.15

 
0.1


RSAs vest on either the first (for RSAs granted in 2013 and later) or the third (for RSAs granted prior to 2013) anniversary of the grant date, provided the holder of the shares is continuously employed by or in the service of the Company until the vesting date. Compensation expense recognized related to the RSAs was $0.3 million for the three months ended April 2, 2016.
As of April 2, 2016, there was $0.1 million of unrecognized compensation cost related to non-vested RSAs that is expected to be recognized as a charge to earnings over a weighted average period of 0.1 years.
Following is a summary of RSU award activity for the three months ended April 2, 2016:

 
 
 
 
Shares
 
Weighted Average Fair Value at Grant Date
 
Weighted Average Remaining Contractual Term (years)
Unvested RSUs at January 2, 2016
 
268,655

 
$
72.91

 
1.8
Granted
 

 

 
 
Vested
 
(420
)
 
72.65

 
 
Forfeited
 
(4,215
)
 
71.52

 
 
Unvested RSUs at April 2, 2016
 
264,020

 
$
72.94

 
1.6


RSU shares vest on the third anniversary of the grant date, provided the holder of the shares is continuously employed by the Company until the vesting date. Compensation expense recognized related to the RSUs was $1.3 million for the three months ended April 2, 2016.
As of April 2, 2016, there was $8.6 million of unrecognized compensation cost related to non-vested RSUs that is expected to be recognized as a charge to earnings over a weighted average period of 1.6 years.
Performance Share Units
Performance share unit ("PSU") awards consist of shares or the rights to shares of the Company's stock which are awarded to employees of the Company. These shares are payable upon the determination that the Company achieved certain established performance targets and can range from 0% to 200% of the targeted payout based on the actual results. PSU's have a performance period of 3 years. As set forth in the individual grant agreements, acceleration of vesting may occur under a change in control, death or disability. There are no voting rights with these instruments until vesting occurs and a share of stock is issued. Some of the PSU awards are valued using a Monte Carlo simulation method as of the grant date while others are valued using the closing market price as of the grant date depending on the performance criteria for the award.
Following is a summary of PSU award activity for the three months ended April 2, 2016:
 
 
 
 
Shares
 
Weighted Average Fair Value at Grant Date
 
Weighted Average Remaining Contractual Term (years)
Unvested PSUs at January 2, 2016
 
87,895

 
$
75.81

 
1.9
Granted
 

 

 
 
Vested
 

 

 
 
Forfeited
 
(235
)
 
87.85

 
 
Unvested PSUs April 2, 2016
 
87,660

 
$
75.78

 
1.7

Compensation expense for awards granted are recognized based on the targeted payout of 100.0%, net of estimated forfeitures. Compensation expense recognized related to PSUs was $0.5 million for the three months ended April 2, 2016. Total unrecognized compensation expense for all PSUs granted as of April 2, 2016 is estimated to be $2.8 million recognized as a charge to earnings over a weighted average period of 1.7 years.